Factors Associated with Response to Systemic Corticosteroids in Active Ulcerative Colitis: Results from a Prospective, Multicenter Trial

Background: Among patients with ulcerative colitis, 30–50% receive corticosteroids within the first five years after diagnosis. We aimed to reconsider their effectiveness in the context of the biologic era. Methods: In this prospective, multicenter study, patients with active ulcerative colitis (Lic...

Descripción completa

Detalles Bibliográficos
Autores principales: Blesl, Andreas, Borenich, Andrea, Gröchenig, Hans Peter, Novacek, Gottfried, Primas, Christian, Reinisch, Walter, Kutschera, Maximilian, Illiasch, Constanze, Hennlich, Barbara, Steiner, Pius, Koch, Robert, Tillinger, Wolfgang, Haas, Thomas, Reicht, Gerhard, Mayer, Andreas, Ludwiczek, Othmar, Miehsler, Wolfgang, Steidl, Karin, Binder, Lukas, Baumann-Durchschein, Franziska, Fürst, Stefan, Reider, Simon, Watschinger, Christina, Wenzl, Heimo, Moschen, Alexander, Berghold, Andrea, Högenauer, Christoph
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10382050/
https://www.ncbi.nlm.nih.gov/pubmed/37510968
http://dx.doi.org/10.3390/jcm12144853

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10382050/
https://www.ncbi.nlm.nih.gov/pubmed/37510968
http://dx.doi.org/10.3390/jcm12144853

Ejemplares similares